2-(benzyloxy)-N-(pyridin-2-yl)benzamide

ID: ALA4471976

PubChem CID: 118911700

Max Phase: Preclinical

Molecular Formula: C19H16N2O2

Molecular Weight: 304.35

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccccn1)c1ccccc1OCc1ccccc1

Standard InChI:  InChI=1S/C19H16N2O2/c22-19(21-18-12-6-7-13-20-18)16-10-4-5-11-17(16)23-14-15-8-2-1-3-9-15/h1-13H,14H2,(H,20,21,22)

Standard InChI Key:  SEZCFUDAWCJEMF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   39.9336   -2.9468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9325   -3.7663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6405   -4.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3502   -3.7659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3474   -2.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6388   -2.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0535   -2.5319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7628   -2.9379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.0505   -1.7148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.4690   -2.5266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0586   -4.1734    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.0598   -4.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7682   -5.3980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7649   -6.2126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4724   -6.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1804   -6.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1765   -5.3888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4684   -4.9851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1766   -2.9359    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.8823   -2.5254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8797   -1.7073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1654   -1.3016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4627   -1.7145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
  4 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 10 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 10  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4471976

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 304.35

Molecular Weight (Monoisotopic): 304.1212

AlogP: 3.91

#Rotatable Bonds: 5

Polar Surface Area: 51.22

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.68

CX LogP: 4.01

CX LogD: 4.01

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.78

Np Likeness Score: -1.42

References

1. Li Y, Huang T, Lou B, Ye D, Qi X, Li X, Hu S, Ding T, Chen Y, Cao Y, Mo M, Dong J, Wei M, Chu Y, Li H, Jiang XC, Cheng N, Zhou L..  (2019)  Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.,  163  [PMID:30580239] [10.1016/j.ejmech.2018.12.028]

Source

Source(1):

• Scientific Literature